Beta-Adrenergic Receptors, from Their Discovery and Characterization through Their Manipulation to Beneficial Clinical Application
Author(s) -
S. Blake Wachter,
Edward M. Gilbert
Publication year - 2012
Publication title -
cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.547
H-Index - 63
eISSN - 1421-9751
pISSN - 0008-6312
DOI - 10.1159/000339271
Subject(s) - adrenergic receptor , receptor , transduction (biophysics) , perspective (graphical) , signal transduction , function (biology) , β2 adrenergic receptor , clinical trial , adrenergic , heart failure , medicine , bioinformatics , neuroscience , computational biology , pharmacology , biology , microbiology and biotechnology , computer science , biochemistry , artificial intelligence , agonist
β-Adrenergic receptors (β-AR) are central to the overall regulation of cardiac function. From the first proposed receptor/transmitter concept to the latest clinical β-blocker trials β-AR have been shown to play an important role in cardiac disease and heart failure in particular. This study provides a historical perspective, reviews the latest discoveries and beliefs, and discusses the current clinical practices of β-AR and their modulation with their associated guanine-nucleotide regulatory protein/adenylylcyclasesignal transduction pathways.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom